EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Encapsulation of SAAP-148 in Octenyl Succinic Anhydride-Modified Hyaluronic Acid Nanogels for Treatment of Skin Wound Infections

Miriam E van Gent iD, Tom van Baaren, Sylvia N Kłodzińska, Muhanad Ali, Natasja Dolezal, Bjorn R van Doodewaerd iD, Erik Bos, Amy M de Waal, Roman I Koning iD, Jan Wouter Drijfhout, Hanne Mørck Nielsen iD, Peter H Nibbering

Pharmaceutics · 28.01.2023 · 15 (2) · 429

DOI: 10.3390/pharmaceutics15020429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 28.01.2023. Verfasst von Miriam E van Gent und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, Novo Nordisk Foundation, Dutch Research Council (NWO), Novel Antibacterial Compounds and Therapies Antagonizing Resistance Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic wound infections colonized by bacteria are becoming more difficult to treat with current antibiotics due to the development of antimicrobial resistance (AMR) as well as biofilm and persister cell formation. Synthetic antibacterial and antibiofilm peptide (SAAP)-148 is an excellent alternative for treatment of such infections but suffers from limitations related to its cationic peptidic nature and thus instability and possible cytotoxicity, resulting in a narrow therapeutic window. Here, we evaluated SAAP-148 encapsulation in nanogels composed of octenyl succinic anhydride (OSA)-modified hyaluronic acid (HA) to circumvent these limitations. SAAP-148 was efficiently (>98%) encapsulated with high drug loading (23%), resulting in monodispersed anionic OSA-HA nanogels with sizes ranging 204–253 nm. Nanogel lyophilization in presence of polyvinyl alcohol maintained their sizes and morphology. SAAP-148 was sustainedly released from lyophilized nanogels (37–41% in 72 h) upon reconstitution. Lyophilized SAAP-148-loaded nanogels showed similar antimicrobial activity as SAAP-148 against planktonic and biofilm-residing AMR Staphylococcus aureus and Acinetobacter baumannii. Importantly, formulated SAAP-148 showed reduced cytotoxicity against human erythrocytes, primary human skin fibroblasts and human keratinocytes. Additionally, lyophilized SAAP-148-loaded nanogels eradicated AMR S. aureus and A. baumannii colonizing a 3D human epidermal model, without inducing any cytotoxicity in contrast to SAAP-148. These findings indicate that OSA-HA nanogels increase SAAP-148′s therapeutic potential for treatment of skin wound infections.

Schlagwörter

Stichwörter der Autor:innen

AMP formulationSAAP-148antimicrobial peptidecutaneous applicationhyaluronic acid-based nanogelsskin wound infections

Autor:innen und Institutionen

  • Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Center for Biopharmaceuticals and Biobarriers in Drug Delivery (BioDelivery), Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark.
  • Department of Immunology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Electron Microscopy Facility, Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

ORCID-Profile: Miriam E van Gent, Bjorn R van Doodewaerd, Roman I Koning, Hanne Mørck Nielsen

Förderung

  • Dutch Research Council
  • Novo Nordisk Foundation
  • Dutch Research Council (NWO), Novel Antibacterial Compounds and Therapies Antagonizing Resistance Program

Zitieren

APA

van Gent, M. E., van Baaren, T., Kłodzińska, S. N., Ali, M., Dolezal, N., van Doodewaerd, B. R., Bos, E., de Waal, A. M., Koning, R. I., Drijfhout, J. W., Nielsen, H. M., & Nibbering, P. H. (2023). Encapsulation of SAAP-148 in Octenyl Succinic Anhydride-Modified Hyaluronic Acid Nanogels for Treatment of Skin Wound Infections. Pharmaceutics, 15(2), 429. https://doi.org/10.3390/pharmaceutics15020429

Vancouver

van Gent ME, van Baaren T, Kłodzińska SN, Ali M, Dolezal N, van Doodewaerd BR, et al. Encapsulation of SAAP-148 in Octenyl Succinic Anhydride-Modified Hyaluronic Acid Nanogels for Treatment of Skin Wound Infections. Pharmaceutics. 2023;15(2):429. doi:10.3390/pharmaceutics15020429

BibTeX
@article{vanGent2023,
  author = {van Gent, Miriam E and van Baaren, Tom and Kłodzińska, Sylvia N and Ali, Muhanad and Dolezal, Natasja and van Doodewaerd, Bjorn R and Bos, Erik and de Waal, Amy M and Koning, Roman I and Drijfhout, Jan Wouter and Nielsen, Hanne Mørck and Nibbering, Peter H},
  title = {Encapsulation of SAAP-148 in Octenyl Succinic Anhydride-Modified Hyaluronic Acid Nanogels for Treatment of Skin Wound Infections},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {429},
  doi = {10.3390/pharmaceutics15020429}
}
Kostenlos starten →